In July 2013 the Jamaica Anti-Doping Commission (JADCO) reported an anti-doping rule violation against the Athlete Sherone Simpson after her A and B samples tested positive for the prohibited substance Oxilofrine. After notification a provisional suspension was ordered. The Athlete filed a statement in her defence and she was heard for the Jamaica Anti-Doping Disciplinary Panel.
The Athlete admitted the violation and stated that it was not intentional. She asserted that one of the supplements Epiphandy D1 she used was the source of the positive test recommended by her physical trainer. She stated that she researched the ingredients of all the supplements she had used. Analysis in 2 laboraties in the USA and in one laboratory in Jamaica of the batch of Epiphandy D1 used by the Athlete showed the presence of the substance Oxilofrine in supplement.
Considering the evidence in this case and the Athlete’s degree of fault the Panel accepts that the violation was not intentional and that there are grounds for a reduced sanction. The Panel deems that the Athlete failed to mention her supplement in question on the Doping Control Form and that the substantial assistance she provided was insufficient enough for a further reduction of the sanction.
Therefore the Jamaica Anti-Doping Disciplinary Panel decides on 1 May 2014 to impose a 18 month period of ineligibility on the Athlete starting on the date of the sample collection, i.e. on 21 June 2013.
